- Home
- Companies
- sierra leone
- in vitro study
Refine by
In Vitro Study Suppliers Serving Sierra Leone
47 companies found
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, appr 30-fold selective for JAK2 than JAK3, and sensitive to JAK2V617F and MPLW515L/K ...
based inCheshire, UNITED KINGDOM
Gentronix is a specialist CRO focused on delivering predictive toxicology products & services to global chemical sectors. Working with companies from early screening through to regulatory safety assessment, we deliver innovative solutions for both ...
The in vitro micronucleus test (MNT) is a main-stay of most regulatory genotoxicity testing strategies, and is used to detect in vitro clastogens and aneugens. In this regard it complements the Ames test well, as ...
based inAlachua, FLORIDA (USA)
RTI Surgical (RTI) is a global, industry leading surgical implant supplier that provides design, new product development, processing and manufacturing services in support of patients and leading medical technology companies. With expertise in tissue ...
RTI Surgical offers the only meniscal allograft with both bone and meniscus sterilized through the BioCleanse® Tissue Sterilization Process. The BioCleanse processed meniscus graft provides a sterilized alternative to traditional aseptically ...
based inParis, FRANCE
Laboratoires Fillmed : A French major playor with an objective of 360° approach to skin rejuvenation. Founded in 1978, FILLMED has been developing high performance products to prevent and correct signs of skin ageing: ART FILLER dermal fillers, NCTF ...
based inLodi, WISCONSIN (USA)
Attwill develops and manufactures pharmaceuticals, medical devices, and biologics in the heart of Wisconsin. Attwill’s scalable production and funding solutions are well equipped to take new ideas from startup to scale. With lyophilization at ...
FILTERGuard™ is a disposable IV filter with CHG. The sterile, single-use disposable IV filter is infused with chlorhexidine gluconate (CHG) to help reduce the incidence of bloodstream infections, local infections and skin colonization in ...
based inLargo, FLORIDA (USA)
CONMED is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical ...
With strong fixation, less bone removal and a simple, self-punching technique, the Y-Knot® RC helps overcome the trade-offs of other rotator cuff fixation methods. The first self-punching all-suture anchor available, Y-Knot® RC anchors can ...
based inMilpitas, CALIFORNIA (USA)
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other ...
based inCorona, CALIFORNIA (USA)
For over 20 years, United Endoscopy has been a leader in providing state-of-the-art refurbished medical equipment and advanced equipment repair to its customers worldwide. Since its founding in 1996 by Jeremy Cooper, United Endoscopy has ...
based inShanghai, CHINA
Bioventus LLC is a medical technology company that specializes in the development and distribution of orthobiologic solutions designed to support bone healing and regeneration. The company is known for its registered trademarks such as OSTEOAMP, ...
OSTEOAMP is backed by science to meet the surgeon's need for a proven allograft that can achieve solid fusion ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Scientific advisory meeting held with MHRA confirming the need of a Phase 3 study to support the improved skin permeation including potential superior efficacy claims. Exploring the feasibility of a clinical study to satisfy the Phase 3 requirements ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inTainan City, TAIWAN
Leadgene Biomedical Inc. is founded in 2013 and headquarters in Tainan, Taiwan. In the past years, we have become an all-around solution provider for proteomics study with more than thirty staff members from a three-scientists workshop, ...
based inLa Rochelle, FRANCE
We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box ...
StarSurf® is a surface treatment process enabling to create a rough structure on the surface of implants made of titanium and titanium alloys thus improving their biological performance of osseointegration. Implants surface finishing plays a ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
TP-0184 is an investigational inhibitor of activin receptor-like kinase 2 (ALK2) and ALK5 (also known as TGFβR1). This bimodal inhibitor is believed to downregulate multiple TGF-β superfamily signaling pathways and has shown antitumor ...
based inPipersville, PENNSYLVANIA (USA)
LAMPIRE specializes in custom polyclonal & monoclonal antibody development, secondary antibodies, IgGs, BSA, animal blood, tissues & organs, normal & disease state human serums & plasmas, cell media, OMNI C3 cell culture bags & contract ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-402 is a monoclonal antibody that targets the human TIE2 that regulated activation, proliferation, and repolarization of Tie2 expressing macrophages, resulting in T cell activation. It binds to TIE2 expressing macrophages that activate T cells ...
based inHillsborough, NEW JERSEY (USA)
LifeTein, located in Somerset, New Jersey, was founded in 2008 with a simple vision: understanding life sciences one protein at a time. This philosophy has formed the foundation of every peptide, protein, antibody, gene, and chemical project that we ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inMississauga, ONTARIO (CANADA)
Covalon Technologies Ltd. (Covalon) develops and commercializes proprietary technologies for major medical device manufacturers. Our partners include the top medical device companies, leaders in urology, wound care, vascular access, venture capital, ...
based inLa Verpillière, FRANCE
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint ...
Off-the-shelf devices available for key identified nasal drugs. Accelerate your sprint to market with our Device Equivalence Program. Based on FDA requirements, we have established a Device Equivalence Program in order to accelerate ...